Barclays’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $28.9M | Buy |
|
|||||
|
2023
Q3 | $5.57M | Buy |
|
|||||
|
2023
Q2 | $3.75M | Sell |
|
|||||
|
2023
Q1 | $5.28M | Sell |
|
|||||
|
2022
Q4 | $10.4M | Buy |
|
|||||
|
2022
Q3 | $8.88M | Buy |
|
|||||
|
2022
Q2 | $800K | Sell |
|
|||||
|
2022
Q1 | $1.99M | Sell |
|
|||||
|
2021
Q4 | $4.76M | Buy |
|
|||||
|
2021
Q3 | $2.67M | Sell |
|
|||||
|
2021
Q2 | $4.86M | Sell |
|
|||||
|
2021
Q1 | $6.73M | Buy |
|
|||||
|
2020
Q4 | $8.42M | Sell |
|
|||||
|
2020
Q3 | $15.5M | Buy |
|
|||||
|
2020
Q2 | $10M | Sell |
|
|||||
|
2020
Q1 | $8.18M | Buy |
|
|||||
|
2019
Q4 | $7.5M | Buy |
|
|||||
|
2019
Q3 | $1.67M | Sell |
|
|||||
|
2019
Q2 | $3.49M | Sell |
|
|||||
|
2019
Q1 | $3.91M | Buy |
|
|||||
|
2018
Q4 | $1.69M | Buy |
|
|||||
|
2018
Q3 | $730K | Sell |
|
|||||
|
2018
Q2 | $1.26M | Sell |
|
|||||
|
2018
Q1 | $1.23M | Buy |
|
|||||
|
2017
Q4 | $328K | Buy |
|
|||||
|
2017
Q3 | $146K | Sell |
|
|||||
|
2017
Q2 | $119K | Buy |
|
|||||
|
2017
Q1 | $33K | Buy |
|
|||||
|
2016
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $21K | Buy |
|
|||||
|
2016
Q1 | $16K | Buy |
|
|||||
|
2015
Q4 | $3K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $6K | Sell |
|
|||||
|
2015
Q1 | $7K | Sell |
|
|||||
|
2014
Q4 | $10K | Buy |
|
|||||
|
2014
Q3 | $4K | Buy |
|
|||||
|
2014
Q2 | $3K | Sell |
|
|||||
|
2014
Q1 | $17K | Buy |
|